Veriray
Where verification equals power.
Empowering Better Outcomes
Through Advanced Radiotherapy Solutions
Who We Are
Veriray is a clinical research organization focused on providing comprehensive oversight in radiation therapy. By ensuring precise delivery and assessing its impact on clinical outcomes, we enable informed decision-making throughout drug development.
Our Expertise
Radiotherapy solutions tailored to your needs.
At Veriray, we specialize in providing comprehensive radiotherapy solutions that enhance the quality and reliability of clinical trials. Our team of experts collaborates with biopharmaceutical companies to ensure precise radiation delivery, robust data integrity, and actionable insights. From protocol development to pattern of failure analysis, we are committed to empowering better outcomes through innovation and excellence in radiation therapy.
Radiation Therapy Protocol Development
Designing precise protocols that ensure accurate radiation delivery, minimize adverse outcomes, and enhance clinical trial consistency.
Radiation Therapy Contouring
Defining tumor volumes with precision to target radiation effectively while protecting healthy tissues and optimizing patient outcomes.
Radiation Therapy Quality Assurance
Implementing rigorous processes to maintain consistent, accurate, and safe delivery of radiation therapy in clinical trials.
Toxicity Attribution
Determining the causes of adverse events with precision, supporting informed decision-making for investigational drugs.
Pattern of Failure Analysis
Providing detailed insights into treatment effectiveness by analyzing recurrence patterns to improve therapeutic outcomes.
Leadership
Dr. Matthew Witek
CEO and Founder
A board-certified radiation oncologist and thought leader in advanced radiation therapy, Dr. Witek brings over a decade of expertise in clinical trial quality assurance and innovative protocol development.
Leigh Howe
Strategic Financial Advisor
With 40 years of experience as a healthcare finance executive and CEO of the Maryland Proton Treatment Center, Ms. Howe will assure Veriray’s growth.
Dr. Mandira Mehra
Chief Innovation Advisor
A double-board-certified physician and industry leader, Dr. Mehra excels in pioneering radiation therapy-based solutions tailored to the biopharmaceutical sector.
Veriray 